Immuneering Corp. (IMRX)

5.02 +0.16 (+3.29%) USD  |  NASDAQ  |  Mar 20, 16:00
5.05 +0.03 (+0.60%) After-Hours: 20:00
More

Immuneering EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Verastem, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
X4 Pharmaceuticals, Inc. Upgrade